SSN 75F40126SSN133878.pdf

THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR

WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION

ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED

FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY

COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO THIS

ANNOUNCEMENT OR ANY FOLLOW-UP INFORMATION REQUESTS. NO

TELEPHONE CALLS WILL BE ACCEPTED REQUESTING AN RFQ PACKAGE OR

SOLICITATION. THERE IS NO RFQ PACKAGE OR SOLICITATION. IN ORDER TO

PROTECT THE PROCUREMENT INTEGRITY OF ANY FUTURE PROCUREMENT,

IF ANY, THAT MAY ARISE FROM THIS ANNOUNCEMENT, INFORMATION

REGARDING THE TECHNICAL POINT OF CONTACT WILL NOT BE GIVEN AND

NO APPOINTMENTS FOR PRESENTATIONS WILL BE MADE.

The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) issues this Sources Sought Notice (SSN) on behalf of Center for Biologics Evaluation and Research (CBER), the Facility for Biotechnology Resources (FBR) in order to determine if there are existing small business sources capable of providing a Preventive Maintenance and unlimited repair agreement for a Thermo Fisher Q Exactive mass spectrometer (S/N: 02092P), plus the instrument-controlling computer and software programs (Xcalibur and DCMSlink for Xcalibur) for a base year plus two (2) possible one-year option years.

The instrument was under a maintenance agreement that expired on December 8, 2025; and since then, the instrument’s turbo-molecular pump went out; therefore, the instrument will require a pre-inspection and repairs to bring the instrument to operational condition prior to the new service contract becoming active. Once the mass spec system has been repaired, the vendor/service provider shall maintain the mass spectrometer system (including vacuum pumps, computer, and other accessories) in a functional state for the periods of performance below.

Period(s) of Performance: Base plus two (2) option years with the following anticipated period of performance dates (Note: the PoPs are estimated; the PoPs will be updated once an actual award date is determined):

Base PoP: 07/31/2026 – 07/30/2027 Option Year 1: 07/31/2027 – 07/30/2028 Option Year 2: 07/31/2028 – 09/30/2029

If your firm is considered a small business source under North American Industry Classification System (NAICS) 811210 – Electronic and Precision Equipment Repair and Maintenance; with a Small Business Size Standard of $34 Million, and you believe that your firm would be able to provide the FDA with the service described below, please submit an email to suzanne.martella@fda.hhs.gov.

Other than small business concerns are also encouraged to submit capability statements. The vendor shall include information about the company and demonstrate that it can meet all of the minimum performance requirements.

mailto:suzanne.martella@fda.hhs.gov

Minimum Performance Requirements for the Preventative Maintenance (PM) and Unlimited Corrective Repairs Service Agreement:

1. The Contractor shall provide one (1) scheduled on-site planned preventive maintenance visit per year which shall include all labor, travel, and OEM factory-certified replacement parts, components, subassemblies, etc., as well as consumables.

2. The Contractor shall provide unlimited on-Site Corrective Maintenance/Repairs within 3 business days of call for service where problems cannot be resolved remotely after 2 business days.

Contractor must provide priority response time (within 24 hours) after initial receipt of service call.

3. The Contractor shall provide certified Original Equipment Manufacturer (OEM) parts for all repairs and maintenance.

4. All maintenance and repair activities shall be performed by service technicians/engineers who are formally trained and certified by the original manufacturer. Engineers shall have access to the manufacturer’s latest technical developments, repair procedures, application updates, diagnostic software, and planned maintenance procedures.

5. All PM services and repairs shall be performed following Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using OEM replacement parts, components, subassemblies, etc.

6. The service plan shall include access to OEM technical developments and unlimited OEM system software, firmware and hardware support and updates, as required by the OEM.

7. Service contract coverage shall include troubleshooting capabilities based on complete knowledge of the entire instrument, immediate access to certified replacement parts, and immediate access to improvements and new procedures provided by the original vendor and manufacturer.

8. The service/maintenance activities shall be performed by formally trained and OEM-certified technicians/engineers who have experience servicing this instrument.

9. Engineers shall have access to the manufacturer’s latest technical developments, repair procedures, application updates, diagnostic software, and planned maintenance procedures.

Services shall be performed following Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using OEM replacement parts, components, subassemblies, etc.

10. The contract shall provide unlimited priority access to technical support Monday through Friday (excluding Federal Holidays) 7:00AM – 5:00PM Eastern Time.

11. The contract shall enable the FDA Technical Point of Contact (TPOC) and system operator personnel to have access to the manufacturer’s call center for technical assistance, which is staffed by senior engineers to provide a high level of expertise for troubleshooting the instrument.

12. Pricing shall be inclusive of labor, travel, replacement parts, components, subassemblies, etc. for the system.

Service Records and Reports: The Contractor shall, commensurate with the completion the preventive maintenance service visit, provide the end-user of the equipment with a copy of a field service report/ticket identifying the equipment name, manufacturer, model number, and serial number of the equipment being serviced, a detailed description of the work performed, the test instruments or other equipment used to perform the service, the name(s) and contact information of the technician who performed the service, and for information purposes, the on-site hours expended, and parts/components replaced.

Place of Performance

The equipment is located, and services shall be performed at the Center for Biologics Evaluation and Research (CBER) at the following address:

US FDA/CBER/FBR

10903 New Hampshire Ave.

Rm 1106, Building 52/72 Silver Spring, MD 20993

Responses to this Sources Sought shall unequivocally demonstrate that the respondent is regularly engaged in the sale of same or substantially similar services. Though the target audience is small business vendors or small businesses capable of supplying a U.S. product/service of a small business vendor or producer, all interested parties may respond. At a minimum, responses shall include the following:

• Business name and bio, Unique Entity ID (SAM) number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. Provide this same information again if responding to provide a service offered by another firm.

• Descriptive literature, brochures, marketing material, etc. detailing the preventive-corrective maintenance services which the responding firm is regularly engaged in providing, including services for the Thermo Fisher Q Exactive mass spectrometer, plus the instrument-controlling computer and software programs (Xcalibur and DCMSlink for Xcalibur. Capability statements must provide sufficient information that unequivocally demonstrates that the technical requirements and/or delivery time identified above can be met.

• Past Performance (within the last 3 years) information for the sale of same or substantially similar product to include date of sale, description of services provided, contract dollar value, client name, client address, client contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include Unique Entity ID (SAM) number and size status) if not the respondent.

• The offeror shall furnish sufficient technical information necessary for the Government to conclusively determine that the offered services meet the technical requirements identified above.

• The offeror’s capability to initiate service within the two-day response-time requirement from original notification.

• If applicable, identification of the firm’s GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested.

• If applicable, identification of Best in Class (BIC) contract information or other Government-wide or HHS-wide contracts that the equipment/service is available on.

• If a large business, provide whether subcontracting opportunities exist for small business concerns.

• Standard commercial warranty and payment terms.

• Provide place of manufacture or any other applicable information to enable review and analysis pertaining to the Buy American statute and requirements relating to Made in America in the event a nonavailability waiver request through the MIAO Digital Waiver Portal is needed.

• Though this is not a request for quote, informational pricing for the products would be helpful for market research purposes.

The Government is not responsible for locating or securing any information not identified in the response.

Interested Contractors must respond with capability statements which are to be submitted by email only to the point of contact listed below on or before 2:00 pm (Central Time in Jefferson AR) on April 20, 2026 to Suzanne Martella, email suzanne.martella@fda.hhs.gov. Reference:

75F40126SSN133878.

Disclaimer and Important Notes

This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work.

Responses with weblinks will not be opened or viewed.

Responses must demonstrate capability, not merely affirm the respondent’s capability (i.e. the response must go beyond the statement that, “XYZ company can provide the instrument, technical support etc.”).

mailto:suzanne.martella@fda.hhs.gov

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

After a review of the responses received, a pre‐solicitation synopsis or combined synopsis/ solicitation may be published in SAM.gov – Contracting Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

Confidentiality and Proprietary Information

No proprietary, classified, confidential, or sensitive information should be included in your response.

The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s).

Additional Notes:

If the stated requirements appear restrictive, please submit comments detailing the concern. Though this is not a request for quote, informational pricing for the service would be helpful.